A comparison of intrathecal diamorphine and intravenous morphine for postoperative analgesia in patients undergoing lumbar spinal surgery

ISRCTN ISRCTN01558905
DOI https://doi.org/10.1186/ISRCTN01558905
Protocol serial number N0015187634
Sponsor Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Funder North Cheshire Hospitals NHS Trust (UK)
Submission date
28/09/2007
Registration date
28/09/2007
Last edited
28/08/2015
Recruitment status
Stopped
Overall study status
Stopped
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Clare Hammell
Scientific

North Cheshire Hospitals NHS Trust
Warrington Hospital
Lovely Lane
Warrington
WA5 1QG
United Kingdom

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleA comparison of intrathecal diamorphine and intravenous morphine for postoperative analgesia in patients undergoing lumbar spinal surgery
Study objectivesIs intrathecal diamorphine injection an effective method for postoperative analgesia in patients following lumbar spinal surgery?

Updated 28/08/2015: The trial was never started due to lack of suitable participants.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedSurgery: Analgesia
InterventionIntrathecal diamorphine vs intravenous morphine
Intervention typeDrug
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Diamorphine, morphine
Primary outcome measure(s)

The quality of postoperative analgesia. Patients pain scores will be measured in recovery and on days 1 and 2 postoperatively using a validated pain assessment tool (visual analogue scale 0-100mm). The assessor will be blinded to the patients treatment group. The amounts of morphine required to achieve adequate analgesia via a PCA system will be recorded in both groups.

Key secondary outcome measure(s)

Secondary outcome measures include the presence of nausea, vomiting, sedation and pruritis.

Completion date01/04/2007
Reason abandoned (if study stopped)Participant recruitment issue

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
Upper age limit70 Years
SexAll
Target sample size at registration80
Key inclusion criteriaAll ASA 1,2 and 3 patients between the ages of 18 to 70 years undergoing lumbar spinal surgery via a posterior surgical approach will be invited to participate in the study.
Key exclusion criteria1. Any contraindications to spinal injection (localised skin sepsis at proposed site of injection, coagulopathy)
2. History of allergy to any of the drugs used in the study
3. Severe hepatic or renal disease
Date of first enrolment01/01/2006
Date of final enrolment01/04/2007

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

North Cheshire Hospitals NHS Trust
Warrington
WA5 1QG
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes